Title:
A NOVEL ALPHA-(N-SULFONAMIDO)ACETAMIDE COMPOUND AS AN INHIBITOR OF BETA AMYLOID PEPTIDE PRODUCTION
Document Type and Number:
WIPO Patent Application WO/2010/107435
Kind Code:
A8
Abstract:
The present invention provides a method for the treatment of head trauma, traumatic brain injury, and/or dementia pugilistica comprising administering a therapeutically effective amount of (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide.
Inventors:
STARRETT JR JOHN E (US)
GILLMAN KEVIN W (US)
OLSON RICHARD E (US)
GILLMAN KEVIN W (US)
OLSON RICHARD E (US)
Application Number:
PCT/US2009/037639
Publication Date:
October 13, 2011
Filing Date:
March 19, 2009
Export Citation:
Assignee:
BRISTOL MYERS SQUIBB CO (US)
STARRETT JR JOHN E (US)
GILLMAN KEVIN W (US)
OLSON RICHARD E (US)
STARRETT JR JOHN E (US)
GILLMAN KEVIN W (US)
OLSON RICHARD E (US)
International Classes:
A61P25/00; A61K31/4245
Attorney, Agent or Firm:
MINGO, Pamela, A. et al. (P.O. Box 4000Princeton, NJ, US)
Download PDF:
Previous Patent: OPTICAL GAGE AND THREE-DIMENSIONAL SURFACE PROFILE MEASUREMENT METHOD
Next Patent: THREE PHASE CAPACITANCE-BASED SENSING
Next Patent: THREE PHASE CAPACITANCE-BASED SENSING